SynRx
SynRx
SynRx
EN CN
EN CN
SynRx SynRx
Using synthetic lethality strategy to target tumor cells with DNA damage repair defects
Science Pipeline Technology
Pipeline
Target
Positioning
Discovery
Hit-to-Lead
Lead
Optimization
IND
Enabling
Clinical Trials
Anticipated Milestones
  • SY001
    HRD solid cancers
    IND filing 2023
  • SY002
    HRD solid cancers
    IND filing 2023
  • SY003
    Solid cancers
    Development candidate in 2023
  • SY004
    Solid cancers
    Development candidate in 2023
  • SY005
    Solid cancers
    Development candidate in 2023
SynRx
About Us Technology & Products News Careers
Business Development bd@synrx.cn
Careers hr@synrx.cn
Address @ Room 201, Building 4, 1390 Cangxing Street, Cangqian Subdistrict, Yuhang District, Hangzhou, Zhejiang @ Room 303, No.1, Lane 88, Shengrong Road, Zhangjiang High-Tech Park, Pudong New District, Shanghai
0571-86360796
Contact
CopyRight 2022 All Right Reserved SynRx Therapeutics 浙ICP备2021033925号 SiteMap
SynRx
SynRx
SynRx
0571-86360796
SynRx